These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8190530)

  • 1. Reduced Na+, K(+)-ATPase activity in patients with pseudohypoaldosteronism.
    Bistritzer T; Evans S; Cotariu D; Goldberg M; Aladjem M
    Pediatr Res; 1994 Mar; 35(3):372-5. PubMed ID: 8190530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocyte Na+,K+-ATPase and nasal potential in pseudohypoaldosteronism.
    Bistritzer T; Kerem E; Berkovitch M; Rapoport MJ; Evans S; Aladjem M
    Clin Endocrinol (Oxf); 2002 May; 56(5):575-80. PubMed ID: 12030906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythrocyte transmembrane Na and K fluxes in pseudohypoaldosteronism.
    Cugini P; Natoli G; Gerlini G; Di Palma L; Rota R; D'Onofrio M; Verna R
    Biochem Med Metab Biol; 1992 Dec; 48(3):241-54. PubMed ID: 1335741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin-aldosterone response, urinary Na/K ratio and growth in pseudohypoaldosteronism patients with mutations in epithelial sodium channel (ENaC) subunit genes.
    Hanukoglu A; Edelheit O; Shriki Y; Gizewska M; Dascal N; Hanukoglu I
    J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):268-74. PubMed ID: 18634878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hook effect: a pitfall leading to misdiagnosis of hypoaldosteronism in an infant with pseudohypoaldosteronism.
    Akin L; Kurtoglu S; Kendirci M; Akin MA; Hartmann MF; Wudy SA
    Horm Res Paediatr; 2010; 74(1):72-5. PubMed ID: 20431271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital pseudohypoaldosteronism: case report and review. Effect of indomethacin during sodium chloride depletion.
    Rampini S; Furrer J; Keller HP; Bucher H; Zachmann M
    Helv Paediatr Acta; 1978 Jun; 33(2):153-67. PubMed ID: 659259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type I pseudohypoaldosteronism includes two clinically and genetically distinct entities with either renal or multiple target organ defects.
    Hanukoglu A
    J Clin Endocrinol Metab; 1991 Nov; 73(5):936-44. PubMed ID: 1939532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Internal desynchronization between circadian rhythms of plasma aldosterone and erythrocyte membrane-bound Na/K-ATPase.
    Cugini P; Letizia C; Murano G; Lucia P; Scavo D; Verna R
    Prog Clin Biol Res; 1987; 227B():219-28. PubMed ID: 2819894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of plasma aldosterone/potassium ratio in hypoaldosteronism.
    Shiah CJ; Wu KD; Tsai DM; Liao ST; Siauw CP; Lee LS
    J Formos Med Assoc; 1995 May; 94(5):248-54. PubMed ID: 7613258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case report: severe neonatal hyperkalemia due to pseudohypoaldosteronism type 1.
    Schweiger B; Moriarty MW; Cadnapaphornchai MA
    Curr Opin Pediatr; 2009 Apr; 21(2):269-71. PubMed ID: 19657313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mutation of the epithelial Na+ channel causes type 1 pseudohypoaldosteronism.
    Bonny O; Knoers N; Monnens L; Rossier BC
    Pediatr Nephrol; 2002 Oct; 17(10):804-8. PubMed ID: 12376807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone deficiency with a hormone profile mimicking pseudohypoaldosteronism.
    Martín-Rivada Á; Argente J; Martos-Moreno GÁ
    J Pediatr Endocrinol Metab; 2020 Nov; 33(11):1501-1505. PubMed ID: 32809961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe pseudohypoaldosteronism in a pair of twins not associated with hydramnios.
    Bistritzer T; Lahat E; Eshel G; Barr J; Hanukoglu A; Aladjem M
    Pediatr Nephrol; 1996 Aug; 10(4):438-41. PubMed ID: 8865238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The enigma of pseudohypoaldosteronism.
    Zennaro MC; Borensztein P; Soubrier F; Armanini D; Corvol P
    Steroids; 1994 Feb; 59(2):96-9. PubMed ID: 8191555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudohypoaldosteronism.
    Blachar Y; Kaplan BS; Griffel B; Levin S
    Clin Nephrol; 1979 Jun; 11(6):281-8. PubMed ID: 477044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudohypoaldosteronism: report of a case presenting as failure to thrive.
    Buzi F; Bezante T; Brunori A; Notarangelo LD; Ugazio AG
    J Pediatr Endocrinol Metab; 1995; 8(1):61-5. PubMed ID: 7584700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multiple type I pseudohypoaldosteronism: neonatal management and outcome].
    Cristina De Frutos Martínez M; Elorza Martínez M; Salas Hernández S; García Sánchez P; Jaso Cortés E; Pérez-Rodríguez J; Quero Jiménez J
    An Esp Pediatr; 2000 Jan; 52(1):47-51. PubMed ID: 11003859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of high salt intake on sodium, potassium-dependent adenosine triphosphatase activity in the erythrocytes of normotensive men.
    Quintanilla AP; Weffer MI; Koh H; Rahman M; Molteni A; del Greco F
    Clin Sci (Lond); 1988 Aug; 75(2):167-70. PubMed ID: 2842105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pseudohypoaldosteronism in infants with salt wasting syndrome. Two case reports].
    Szalecki M; Wójcik E; Domagała Z; Małunowicz E
    Pediatr Endocrinol Diabetes Metab; 2007; 13(1):33-6. PubMed ID: 17493404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Primary hypoaldosteronism, pseudo-hypoaldosteronism and distal tubular acidosis].
    Klaus D
    Klin Wochenschr; 1984 Aug; 62(16):747-52. PubMed ID: 6384650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.